Additionally, a post-hoc analysis of the LixiRam randomized trial's data was done [40] to evaluate the safety of a treatment plan using lixisenatide and basal insulin in people with type 2 diabetes mellitus (T2DM) while fasting during Ramadan was examined in the study. Here, INS is linked to diabetes mellitus.